Skin test evaluation of a novel peptide carrier–based vaccine, BM32, in grass pollen–allergic patients - 06/10/15
Doi : 10.1016/j.jaci.2015.03.034
Verena Niederberger, MD a 
, Katharina Marth, MD a, b, Julia Eckl-Dorna, MD, PhD a, Margarete Focke-Tejkl, PhD b, Milena Weber, MSc b, Wolfgang Hemmer, PhD c, Uwe Berger, MBA a, Angela Neubauer, PhD d, Frank Stolz, PhD d, Rainer Henning, PhD d, Rudolf Valenta, MD b
, Katharina Marth, MD a, b, Julia Eckl-Dorna, MD, PhD a, Margarete Focke-Tejkl, PhD b, Milena Weber, MSc b, Wolfgang Hemmer, PhD c, Uwe Berger, MBA a, Angela Neubauer, PhD d, Frank Stolz, PhD d, Rainer Henning, PhD d, Rudolf Valenta, MD b a Department of Otorhinolaryngology, Medical University of Vienna, Vienna, Austria
b Division of Immunopathology, Department of Pathophysiology and Allergy Research, Centre for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria
c FAZ – Floridsdorf Allergy Center, Vienna, Austria
d Biomay AG, Vienna, Austria
| This study was funded by Biomay AG, Vienna, Austria, the Christian Doppler Laboratory for Allergy Research, by the SFB Program F46 of the Austrian Science Fund (FWF, grants nos. F4605 and F4613), and the Austrian Research Promotion Agency (grant nos. 830432 and 835415). |
|
| Disclosure of potential conflict of interest: V. Niederberger has received consultancy fees from Biomay AG, and her institution has recently received funding for other studies from Biomay AG. K. Marth has received payment for delivering lectures from Thermo Fisher. J. Eckl-Dorna's institution has received funding from the Austrian Science Fund (FWF). A. Neubauer, F. Stolz, and R. Henning are employees and shareholders of Biomay AG, which has received grants from the Austrian Research Promotion Agency (FFG; grant nos. 830432 and 835415) and receives royalties from Thermo Fisher. R. Valenta's institution has received funding from the FWF, Biomay AG, and Thermo Fisher; he has received consultancy fees from Biomay AG and Thermo Fisher. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2015
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 136 - N° 4
P. 1101 - octobre 2015 Retour au numéro
Article précédent
- The IL-1 axis is associated with airway inflammation after O3 exposure in allergic asthmatic patients
- Maria M. Aleman, Matthew J. Kesic, Katherine H. Mills, David B. Peden, Michelle L. Hernandez
- Association between parental age and asthma in a population-based register study
- Catarina Almqvist, Henrik Olsson, Vilhelmina Ullemar, Brian M. D'Onofrio, Emma Frans, Cecilia Lundholm
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?